Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Syneos Health Inc (SYNH)

Syneos Health Inc (SYNH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Syneos Health's (SYNH) New Buyout Boosts Clinical Solutions Arm

Syneos Health (SYNH) acquisition of StudyKIK strengthens the former's ability to provide technology and insight-driven solutions.

OMCL : 154.25 (-1.31%)
HSIC : 78.10 (+0.64%)
SYNH : 96.31 (+0.30%)
BRBR : 31.81 (-0.28%)
Syneos Health (SYNH) Enhances Clinical Trials With New Pact

Syneos Health (SYNH) recent partnership develops a more patient-centric travel experience, advances diversity and inclusion in clinical research.

HSIC : 78.10 (+0.64%)
SYNH : 96.31 (+0.30%)
NVST : 43.28 (+1.45%)
BRBR : 31.81 (-0.28%)
Novan Announces Strategic Priorities and Outlines Key Milestones

- Company planning for three potential New Drug Application (NDA) filings in three years with the first submission expected in Q3 2022 for lead program SB206 in molluscum contagiosum -

NOVN : 8.14 (-3.78%)
SYNH : 96.31 (+0.30%)
Syneos Health (SYNH) Up 11.8% Since Last Earnings Report: Can It Continue?

Syneos Health (SYNH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

SYNH : 96.31 (+0.30%)
Novan Engages Syneos Health as Commercial Solutions Provider for SB206

- Company targeting New Drug Application (NDA) for SB206 in Q3 2022, following recent clinically and statistically significant topline efficacy results from a pivotal Phase 3 B-SIMPLE4 trial in patients...

NOVN : 8.14 (-3.78%)
SYNH : 96.31 (+0.30%)
Syneos Health (SYNH) Hits a 52-Week High: What's Driving It?

Strong performance by the Clinical Solutions and Commercial Solutions segments drove Syneos Health's (SYNH) top line.

LH : 296.37 (-0.12%)
OMCL : 154.25 (-1.31%)
CPSI : 35.51 (-1.06%)
SYNH : 96.31 (+0.30%)
Syneos Health to Present at the 2021 Baird Global Healthcare Conference

Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that Chief Executive Officer Alistair Macdonald and Chief Financial Officer Jason Meggs...

SYNH : 96.31 (+0.30%)
Syneos Health (SYNH) Q2 Earnings Top Estimates, 2021 View Up

Syneos Health (SYNH) reported better-than-expected revenues for the second quarter of 2021 on strong segmental performance.

WST : 457.11 (+0.42%)
BRKR : 84.58 (-0.34%)
SYNH : 96.31 (+0.30%)
EHC : 77.01 (+0.86%)
Syneos Health (SYNH) Surpasses Q2 Earnings and Revenue Estimates

Syneos Health (SYNH) delivered earnings and revenue surprises of 3.19% and 0.71%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

SYNH : 96.31 (+0.30%)
Syneos Health Reports Second Quarter 2021 Results

Highlights

SYNH : 96.31 (+0.30%)

Barchart Exclusives

China Completes its Crackdown on Cryptocurrencies
Cryptocurrency prices are sinking today after China’s central bank (PBOC) said all crypto-related transactions are illegal. Bitcoin (^BTCUSD ) is down more than -5%, and Ethereum (^ETHUSD ) is down more than -8%. Crypto-currency-related stocks are getting hammered today as well, with Riot Blockchain (RIOT ) down more than -6%,... Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar